Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis

Journal of Neuroscience Research

Volumn 81, Issue 5, 2005, Pages 687-695

  Bizzozero, Oscar A ^a   DeJesus, Gisela ^a   Callahan, Kelly ^a   Pastuszyn, Andrzej ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Gray matter; Multiple sclerosis; NAWM; Oxidative damage; Protein carbonylation

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; ANTIOXIDANT; CARBONYL DERIVATIVE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; THIOL; PROTEIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; ASTROCYTOSIS; CARBONYLATION; CONTROLLED STUDY; ELECTROPHORESIS; GRAY MATTER; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; WHITE MATTER; BRAIN; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PROTEINS; REACTIVE OXYGEN SPECIES;

EID: 27244450879     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20587     Document Type: Article

References (61)

1. Adalsteinsson E, Langer-Gould A, Homer RJ, Rao A, Sullivan EV, Lima CA, Pfefferbaum A, Atlas SW. 2003. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. Am J Neuroradiol 24:1941-1945.
2. Andrus PK, Fleck TJ, Gurney ME, Hall ED. 1998. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 71:2041-2048.
3. Barkhatova VP, Zavalishin IA, Askarova LS, Shavratskii VK, Demina EG. 1998. Changes in neurotransmitters in multiple sclerosis. Neurosci Behav Physiol 28:341-344.
4. Berlett BS, Stadtman ER. 1997. Protein oxidation in aging, disease and oxidative stress. J Biol Chem 272:20313-20316.
5. Bidlingmeyer BA, Cohen SA, Tarvin TL. 1984. Rapid analysis of amino acids using precolumn derivatization. J Chromatogr 336:93-104.
6. Bizzozero OA, DeJesus G, Bixler HA, Pastuszyn A. 2004. Evidence of nitrosative damage in multiple sclerosis. J Neurochem 90(Suppl 1):BP9-BP13.
7. Bizzozero OA, DeJesus G, Bixler HA, Pastuszyn A. 2005. Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis. Neurochem Res 30:139-149.
8. Bondy SC, LaBel CP. 1993. The relationship between excitotoxicity and oxidative stress in the central nervous system. Free Rad Biol Med 14:633-642.
9. Bongarzone ER, Pasquini JM, Soto EF. 1995a. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J Neurosci Res 41:213-221.
10. Bongarzone ER, Soto EF, Pasquini JM. 1995b. Increased susceptibility to degradation by trypsin and subtilisin of in vitro peroxidized myelin proteins. Neurochem Res 20:421-426.
11. Brett R, Rumsby MG. 1993. Evidence of free radical damage in the central nervous system of guinea-pigs at the prolonged acute and early relapse stages of chronic relapsing experimental allergic encephalomyelitis. Neurochem Int 23:35-44.
12. Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates T, Stella AM, Pennisi G. 2002. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes of glutathione levels. J Neurosci Res 70:580-587.
13. Cao G, Cutler RG. 1995. Protein oxidation and aging. I. Difficulties in measuring reactive protein carbonyls in tissues using 2, 4- dinitrophenylhydrazine. Arch Biochem Biophys 320:106-114.
14. De Stefano N, Mathews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, Federico A, Smith SM. 2003. Early evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60:1157-1162.
15. Di Simplicio P, Franconi F, Frosali S, Giuseppe D. 2002. Thiolation and nitrosation of cysteines in biological fluids. Amino Acids 25:323-339.
16. Fagan JM, Sleczka BG, Sohar I. 1999. Quantitation of oxidative damage to tissue proteins. Int J Biochem Cell Biol 31:751-757.
17. Fisher M, Levine PH, Weiner BH, Vaudreuil CH, Natale A, Johnson MH, Hoogasian JJ. 1988. Monocyte and polymorphonuclear leukocyte toxic oxygen metabolite production in multiple sclerosis. Inflammation 12:123-131.
18. Friguet B, Szweda LI, Stadtman ER. 1994. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch Biochem Biophys 311:168-173.
19. Hafler DA. 2004. Multiple sclerosis. J Clin Invest 113:788-794.
20. Hammann KP, Hopf HC. 1986. Monocytes constitute the only peripheral blood cell population showing an increased burst activity in multiple sclerosis patients. Int Arch Allergy Appl Immunol 81:230-234.
21. Hellings N, Raus J, Stinissen P. 2002. Insights into the immunopathogenesis of multiple sclerosis. Immunol Res 25:27-51.
22. Hunter MS, Neldmadin S, Davidson DLW. 1985. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem Res 10:1645-1652.
23. 1H spectroscopic imaging. Ann Neurol 36:157-165.
24. Inglese M, Ge Y, Filippi M, Falini A, Grossman RI, Gonen O. 2004a. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage 21:1825-1829.
25. Inglese M, Liu S, Babb JS, Mannon IL, Grossman RI, Gonen O. 2004b. Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. Neurology 63:170-172.
26. Janero DR. 1990. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Rad Biol Med 9:515-540.
27. Keegan BM, Noseworthy JH. 2002. Multiple sclerosis. Annu Rev Med 53:285-302.
28. Konat GW, Wiggins RC. 1985. Effect of reactive oxygen species on myelin membrane proteins. J Neurochem 45:1113-1118.
29. Langemann H, Kabiersch A, Newcombe J. 1992. Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques from patients with multiple sclerosis. Eur Neurol 32:248-252.
30. LeVine SM. 1992. The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Med Hypoth 39:271-274.
31. LeVine SM, Weltzel DL. 1998. Chemical analysis of multiple sclerosis lesions by FT-IR microspectroscopy. Free Rad Biol Med 25:33-41.
32. Levine RL, Williams JR, Stadtman ER, Schacter E. 1994. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346-357.
33. Liu JS, Zhao ML, Brosnan CF, Lee SC. 2001. Expression of inducible nitric oxide synthetase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 158:2057-2066.
34. Lucchinetti CF, Bruck W, Rodriguez M, Lassman H. 1996. Distinct patterns of multiple sclerosis pathology indicate heterogeneity in pathogenesis. Brain Pathol 6:259-274.
35. Lumsden C. 1970. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Vol 9, multiple sclerosis and other demyelinating disorders. Amsterdam: Elsevier. p 217-309.
36. MacMicking JD, Willenborg DO, Weidemann MJ, Rockett KA, Cowden WB. 1992. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J Exp Med 176:303-307.
37. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84:407-412.
38. Naidoo R, Knapp ML. 1992. Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. Clin Chem 38:2449-2454.
39. Newcombe J, Cruzner M, Rioytta M, Frey H. 1980. White matter proteins in multiple sclerosis. J Neurochem 34:700-708.
40. Norton W, Poduslo S. 1973. Myelination in rat brain: method of myelin isolation. J Neurochem 21:749-757.
41. Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, Lassmann H. 1994. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117:1311-1322.
42. Perry TL, Hansenn S, Gandham SS. 1981. Postmortem changes of amino compounds in human and rat brain. J Neurochem 36:406-412.
43. Pitt D, Werner P, Raine CS. 2000. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6:67-70.
44. Riddles PW, Blakely RL, Zerner B. 1979. Ellman's reagent: 5, 5′-dithiobis(2-nitrobenzoic acid)-a reexamination. Anal Biochem 94:75-81.
45. Ruuls SR, Bauer J, Sontrop K, Huitinga I, Hart BA, Dijkstra CD. 1995. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 56:207-217.
46. 1H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. J Neurol 249:902-910.
47. Sharma R, Narayama PA, Wolinsky JS. 2001. Gray matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler 7:221-226.
48. 1H-magnetic resonance spectroscopy study. J Neurol Sci 182:143-150.
49. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR. 1991. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheirmer disease. Proc Natl Acad Sci U S A 88:10540-10543.
50. Smith KJ, Kapoor R, Felts PA. 1999. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 9:69-92.
51. Smith T, Groom A, Zhu B, Turski L. 2000. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6:62-66.
52. Stadtman ER. 1990. Covalent modification reactions are making steps for protein turnover. Biochem J 29:6323-6331.
53. Stadtman ER, Berlett BS. 1997. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 10:485-494.
54. Stover JF, Pleines UE, Morganti-Kossmann MC, Kossmann T, Lowitzsch K, Kempski OS. 1997. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest 27:1038-1043.
55. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
56. Trotter J, Wegescheide C, Garvey W, Tourtellote W. 1984. Studies of myelin proteins in multiple sclerosis brain tissue. Neurochem Res 9:147-152.
57. Van der Goes A, Brouwer J, Hoekstra K, Roos D, Van der Berg TK, Dijstra CD. 1998. Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J Neuroimmunol 92:67-75.
58. Vatassery GT, Younoszai R, Vladimirova O, O'Connor J, Cahill A, Alder H, Butunoi C, Kalman B. 1998. Oxidative damage to DNA in plaques of MS brains. Mult Scler 4:413-418.
59. Werner P, Pitt D, Raine CS. 2001. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50:169-180.
60. Yan LJ, Sohal RS. 1998. Gel electrophoretic quantitation of protein carbonyls derivatized with tritiated sodium borohydride. Anal Biochem 265:176-182.
61. Yu TW, Ong CN. 1999. Lag-time measurement of antioxidant capacity using myoglobin and 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid): rationale, application and limitation. Anal Biochem 275:217-223.